Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2008
11/27/2008CA2688784A1 Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
11/27/2008CA2688776A1 Oxo bridged diazepan orexin receptor antagonists
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687956A1 Method for producing pharmaceutical tablet
11/27/2008CA2687955A1 Crystalline micropowder particles
11/27/2008CA2687679A1 Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment
11/27/2008CA2687611A1 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
11/27/2008CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008CA2687528A1 Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating acute mania
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687521A1 Use of trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating schizophrenia
11/27/2008CA2687289A1 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
11/27/2008CA2687117A1 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
11/27/2008CA2686851A1 Fused-ring heterocycle opioids
11/27/2008CA2685858A1 Di-substituted amides for enhancing glutamatergic synaptic responses
11/27/2008CA2685606A1 Use of pimavanserin in the treatment of parkinson and symptoms thereof
11/27/2008CA2685318A1 5-(aminoazacyclyl)-3-sulfonyl-1h-indazoles as 5-hydroxytryptamine-6 ligands for the treatment of cns disorders
11/27/2008CA2684946A1 Treatment of synucleinopathies
11/27/2008CA2683276A1 Ziprasidone formulations
11/27/2008CA2681480A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1995241A1 Inhibitors of ion channels
11/26/2008EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
11/26/2008EP1994939A1 Pharmaceutical composition containing ghrp-6 capable of preventing and eliminating fibrosis and other forms of pathological deposit in tissue
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994932A1 Use of N-desmethylclozapine to treat human psychosis
11/26/2008EP1994032A1 Pyrazole derivatives as sigma receptor inhibitors
11/26/2008EP1994022A2 N-substituted-azacyclylamines as histamine-3 antagonists
11/26/2008EP1994010A1 Compounds which inhibit the glycine transporter and uses thereof
11/26/2008EP1994009A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones
11/26/2008EP1994008A2 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/26/2008EP1993995A1 Amino acid derivatives
11/26/2008EP1993612A2 Compositions and methods for treating cognitive disorders
11/26/2008EP1993607A2 Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
11/26/2008EP1993590A2 Compostions and methods for administering gdnf ligand family proteins
11/26/2008EP1993587A2 Use of the engrailed homeodomain protein as an anxiolytic
11/26/2008EP1993580A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction
11/26/2008EP1993575A2 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
11/26/2008EP1993558A2 Oxysterol compounds and the hedgehog pathway
11/26/2008EP1993552A2 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders
11/26/2008EP1993533A2 Use of nefopam for the treatment of affective disorders
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1993529A1 Alpha-2-delta ligands for non-restorative sleep
11/26/2008EP1993527A2 Inhibiting amyloid-beta peptide/rage interaction at the blood-brain barrier
11/26/2008EP1993523A2 Compositions and methods for treatment of disorders of protein aggregation
11/26/2008EP1993477A2 Transplantation of neural cells
11/26/2008EP1809662B1 Deamidated interferon-beta
11/26/2008EP1603877B1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1392258B1 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP0969875B1 Naked dna-mediated gene transfer into medullary motor neurons
11/26/2008CN101312978A 2-heteroaryl-pyrazolo-[4, 3-e]-1, 2, 4-triazolo-[1,5-c]-pyrimidine as adenosine a2a receptor antagonists
11/26/2008CN101312976A Spirocyclic compounds as hdac inhibitors
11/26/2008CN101312972A Bicyclic cinnamide compound
11/26/2008CN101312968A Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
11/26/2008CN101312965A Morpholine type cinnamide compound
11/26/2008CN101312964A 4-oxadiazolyl-piperidine compounds and use thereof
11/26/2008CN101312961A Isoquinoline and benzo[H]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine h3 receptor
11/26/2008CN101312950A Alkyl sulfoxide quinolines as nk-3 receptor ligands
11/26/2008CN101312728A Pharmaceutical composition for improvement of cognitive function
11/26/2008CN101312726A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312725A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312724A Tetrahydro-indazolyl cannabinoid modulators
11/26/2008CN101312722A Modulators of atp-binding cassette transporters
11/26/2008CN101311273A Biosynthesis gamma-aminobutyric acid preparation and method for preparing same
11/26/2008CN101311181A Aminomethyl-substituted thiazolobenzimidazole derivative
11/26/2008CN101311176A Isoquinoline compounds, preparation method and use thereof
11/26/2008CN101311171A Compound with dual restraining activities to acetyl cholinesterase and butyryl cholinesterase and use thereof
11/26/2008CN101310772A Nitric oxide donors for inducing neurogenesis
11/26/2008CN101310771A Visual function disorder improving agents
11/26/2008CN101310763A Toutongling
11/26/2008CN101310762A Facial paralysis recovery powder medicine
11/26/2008CN101310758A Anti-anxiety compound traditional Chinese medicine and preparation method thereof
11/26/2008CN101310753A Analgesic and anticancer plaster and preparation method thereof
11/26/2008CN101310751A Traditional Chinese medicine composition for replenishing qi and blood, preparation method and quality control method thereof
11/26/2008CN101310747A Novel traditional Chinese drug composition for treating apoplectic hemiplegia and removing phlegm
11/26/2008CN101310740A Anti-anxiety compound traditional Chinese medicine and preparation method thereof
11/26/2008CN101310728A Free protein blood of pig injection and use thereof
11/26/2008CN101310725A Medicine composition for treating all kinds of cancer ache
11/26/2008CN101310724A Uses of adenosine a2alpha receptor antagonists
11/26/2008CN101310723A Use of compounds that are effective as selective opiate receptor modulators
11/26/2008CN101310715A Tanshinol for preparing the medicine for preventing and treating depression and sodium salt thereof
11/26/2008CN101310710A Double sodium valproate orally disintegrating tablets and preparation method thereof
11/26/2008CN101310622A Method for preparing microbial fat with low-content non saponifying objects and the fat
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436453C Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436447C Compounds possessing neuronal activity
11/26/2008CN100436446C Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100436421C Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
1 ... 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 ... 1833